269 related articles for article (PubMed ID: 37721278)
1. Role of CD36 in central nervous system diseases.
Feng M; Zhou Q; Xie H; Liu C; Zheng M; Zhang S; Zhou S; Zhao J
Neural Regen Res; 2024 Mar; 19(3):512-518. PubMed ID: 37721278
[TBL] [Abstract][Full Text] [Related]
2. CD36, a class B scavenger receptor, is expressed on microglia in Alzheimer's disease brains and can mediate production of reactive oxygen species in response to beta-amyloid fibrils.
Coraci IS; Husemann J; Berman JW; Hulette C; Dufour JH; Campanella GK; Luster AD; Silverstein SC; El-Khoury JB
Am J Pathol; 2002 Jan; 160(1):101-12. PubMed ID: 11786404
[TBL] [Abstract][Full Text] [Related]
3. CD36 - A novel molecular target in the neurovascular unit.
Ioghen O; Chițoiu L; Gherghiceanu M; Ceafalan LC; Hinescu ME
Eur J Neurosci; 2021 Apr; 53(8):2500-2510. PubMed ID: 33560561
[TBL] [Abstract][Full Text] [Related]
4. CD36 as a therapeutic target for endothelial dysfunction in stroke.
Cho S
Curr Pharm Des; 2012; 18(25):3721-30. PubMed ID: 22574985
[TBL] [Abstract][Full Text] [Related]
5. β-amyloid protein induces mitophagy-dependent ferroptosis through the CD36/PINK/PARKIN pathway leading to blood-brain barrier destruction in Alzheimer's disease.
Li J; Li M; Ge Y; Chen J; Ma J; Wang C; Sun M; Wang L; Yao S; Yao C
Cell Biosci; 2022 May; 12(1):69. PubMed ID: 35619150
[TBL] [Abstract][Full Text] [Related]
6. A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation.
Bamberger ME; Harris ME; McDonald DR; Husemann J; Landreth GE
J Neurosci; 2003 Apr; 23(7):2665-74. PubMed ID: 12684452
[TBL] [Abstract][Full Text] [Related]
7. Discovery of antagonists for human scavenger receptor CD36 via an ELISA-like high-throughput screening assay.
Wang L; Bao Y; Yang Y; Wu Y; Chen X; Si S; Hong B
J Biomol Screen; 2010 Mar; 15(3):239-50. PubMed ID: 20150587
[TBL] [Abstract][Full Text] [Related]
8. CD36 in Alzheimer's Disease: An Overview of Molecular Mechanisms and Therapeutic Targeting.
Dobri AM; Dudău M; Enciu AM; Hinescu ME
Neuroscience; 2021 Jan; 453():301-311. PubMed ID: 33212223
[TBL] [Abstract][Full Text] [Related]
9. Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner.
Bao Y; Wang L; Xu Y; Yang Y; Wang L; Si S; Cho S; Hong B
Atherosclerosis; 2012 Jul; 223(1):152-9. PubMed ID: 22658257
[TBL] [Abstract][Full Text] [Related]
10. Expression cloning of SR-BI, a CD36-related class B scavenger receptor.
Acton SL; Scherer PE; Lodish HF; Krieger M
J Biol Chem; 1994 Aug; 269(33):21003-9. PubMed ID: 7520436
[TBL] [Abstract][Full Text] [Related]
11. Molecular and functional characterization of the scavenger receptor CD36 in zebrafish and common carp.
Fink IR; Benard EL; Hermsen T; Meijer AH; Forlenza M; Wiegertjes GF
Mol Immunol; 2015 Feb; 63(2):381-93. PubMed ID: 25306962
[TBL] [Abstract][Full Text] [Related]
12. Scavenger receptor class B, type 1 facilitates cellular fatty acid uptake.
Wang W; Yan Z; Hu J; Shen WJ; Azhar S; Kraemer FB
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158554. PubMed ID: 31678516
[TBL] [Abstract][Full Text] [Related]
13. The Past and Present Lives of the Intraocular Transmembrane Protein CD36.
Yang R; Liu Q; Zhang M
Cells; 2022 Dec; 12(1):. PubMed ID: 36611964
[TBL] [Abstract][Full Text] [Related]
14. beta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins.
Kunjathoor VV; Tseng AA; Medeiros LA; Khan T; Moore KJ
J Neuroinflammation; 2004 Nov; 1(1):23. PubMed ID: 15546489
[TBL] [Abstract][Full Text] [Related]
15. CD36 is involved in high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells.
Hou Y; Wu M; Wei J; Ren Y; Du C; Wu H; Li Y; Shi Y
Biochem Biophys Res Commun; 2015 Dec 4-11; 468(1-2):281-6. PubMed ID: 26505798
[TBL] [Abstract][Full Text] [Related]
16. CD36 upregulation mediated by intranasal LV-NRF2 treatment mitigates hypoxia-induced progression of Alzheimer's-like pathogenesis.
Wang CY; Wang ZY; Xie JW; Cai JH; Wang T; Xu Y; Wang X; An L
Antioxid Redox Signal; 2014 Dec; 21(16):2208-30. PubMed ID: 24702189
[TBL] [Abstract][Full Text] [Related]
17. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system.
Husemann J; Loike JD; Anankov R; Febbraio M; Silverstein SC
Glia; 2002 Nov; 40(2):195-205. PubMed ID: 12379907
[TBL] [Abstract][Full Text] [Related]
18. Identification of Inhibitors of CD36-Amyloid Beta Binding as Potential Agents for Alzheimer's Disease.
Doens D; Valiente PA; Mfuh AM; X T Vo A; Tristan A; Carreño L; Quijada M; Nguyen VT; Perry G; Larionov OV; Lleonart R; Fernández PL
ACS Chem Neurosci; 2017 Jun; 8(6):1232-1241. PubMed ID: 28150942
[TBL] [Abstract][Full Text] [Related]
19. Cd36, a member of the class b scavenger receptor family, as a receptor for advanced glycation end products.
Ohgami N; Nagai R; Ikemoto M; Arai H; Kuniyasu A; Horiuchi S; Nakayama H
J Biol Chem; 2001 Feb; 276(5):3195-202. PubMed ID: 11035013
[TBL] [Abstract][Full Text] [Related]
20. Commentary on Myers et al.: growing role of the innate immunity receptor CD36 in central nervous system diseases.
Garcia-Bonilla L; Park L; Iadecola C
Exp Neurol; 2014 Nov; 261():633-7. PubMed ID: 25157902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
